Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

NIH Grants & Funding for Bone Marrow Cancer | Kisho | Kisho

Back to Bone Marrow Cancer

Bone Marrow Cancer — NIH Grants & Funding

Active and recent NIH-funded research on Bone Marrow Cancer. Data from NIH RePORTER, last 36 months.

MONDO:0021138

Looking for specific grants? The Recent Research tab lets you search and filter by topic.

Funding Landscape

Bone Marrow Cancer has a robust NIH research funding landscape with 21 funded grants and $14.1M in total funding over the period.

21funded grants from NIH

Portfolio: $8.5MCumulative: $14.1M9 active12 completed22 PIs17 institutions

+146% YoY(FY2024 vs FY2025)

1 new grant started in the last 12 months.

By Research Theme

Basic Science

Translational

Clinical

Epi / Nat. History

Gene/Cell Therapy

2 additional grants classified as “Other” (multi-disciplinary, infrastructure, etc.).

Funding by Fiscal Year

NIH fiscal year (Oct–Sep)

$1.9M

FY22

$2.9M

FY23

$2.7M

FY24

$6.6M

FY25

By Funding Mechanism

R01

F31

K08

R00

ZIA

F32

Adjacent Research(7 grants)

These grants mention Bone Marrow Cancer as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.

Other(7)

OtherR01Active

Mechanisms and therapeutic implications of human clonal hematopoiesis (CH) mutations

Papapetrou, Eirini·ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI·NEW YORK, NY

$671,875 (FY2025)

NIH RePORTER

OtherR44Active

A Dose Expansion Study of SX-682 Alone and in Combination with Decitabine in MDS Patients

Schuler, Aaron et al.·SYNTRIX BIOSYSTEMS, INC.·AUBURN, WA

$627,270 (FY2025)

NIH RePORTER

OtherR03Active

DNA damage responses to genome editing in hematopoietic stem cells

Doerfler, Phillip·VERSITI BLOOD HEALTH, INC.·MILWAUKEE, WI

$242,048 (FY2025)

NIH RePORTER

OtherR33Completed

Preclinical development of a nuclear-targeting biologic that safely increases stem cell expansion in vivo to accelerate recovery from neutropenia after chemotherapy and bone marrow transplant

Elser, Jeremy·SHIP OF THESEUS, LLC·Eagleville, PA

$213,500 (FY2024)

NIH RePORTER

OtherR01Completed

The Metabolic Regulation of Hematopoietic Stem Cell Function

MORRISON, SEAN·UT SOUTHWESTERN MEDICAL CENTER·DALLAS, TX

$364,500 (FY2022)

NIH RePORTER

OtherR01Completed

Urinary DNA Adductomics for the Assessment of Exposure to Cancer Risk Factors

Cooke, Marcus et al.·UNIVERSITY OF SOUTH FLORIDA·TAMPA, FL

$138,252 (FY2023)

NIH RePORTER

OtherF32Completed

The role of differential bone marrow immune landscape in permissive tumor growth in the spine

Strong, Michael·UNIVERSITY OF MICHIGAN AT ANN ARBOR·ANN ARBOR, MI

$74,234 (FY2022)

NIH RePORTER

Kisho

Bone Marrow Cancer — NIH Grants & Funding

Funding Landscape

By Research Theme

Funding by Fiscal Year

By Funding Mechanism

Adjacent Research(7 grants)

Other(7)

Mechanisms and therapeutic implications of human clonal hematopoiesis (CH) mutations

A Dose Expansion Study of SX-682 Alone and in Combination with Decitabine in MDS Patients

DNA damage responses to genome editing in hematopoietic stem cells

Preclinical development of a nuclear-targeting biologic that safely increases stem cell expansion in vivo to accelerate recovery from neutropenia after chemotherapy and bone marrow transplant

The Metabolic Regulation of Hematopoietic Stem Cell Function

Urinary DNA Adductomics for the Assessment of Exposure to Cancer Risk Factors

The role of differential bone marrow immune landscape in permissive tumor growth in the spine

Top Funded Institutions

Top Principal Investigators